Vimarsana
Biggest News Aggregation in the World

Page 8 - Exact Science News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Exact Science. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Exact Science Today - Breaking & Trending Today

Exact Sciences to participate in November investor conferences - Vimarsana News

Exact Sciences to participate in November investor conferences

/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will...

Cramer's Lighting Round: 'Stay away' from HF Sinclair - Vimarsana News

Cramer's Lighting Round: 'Stay away' from HF Sinclair

"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.

Source: cnbc.com
Next-Generation Cologuard® Test Demonstrates High Sensitivity and Specificity in Pivotal BLUE-C Study, Significantly Outperforming Fecal Immunochemical Testing (FIT) for Cancer and Precancer Detection - Vimarsana News

Next-Generation Cologuard® Test Demonstrates High Sensitivity and Specificity in Pivotal BLUE-C Study, Significantly Outperforming Fecal Immunochemical Testing (FIT) for Cancer and Precancer Detection

/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced late-breaking data from the...

HH&L Acquisition (NYSE:HHLA) versus Exact Sciences (NASDAQ:EXAS) Head to Head Contrast - Vimarsana News

HH&L Acquisition (NYSE:HHLA) versus Exact Sciences (NASDAQ:EXAS) Head to Head Contrast

HH&L Acquisition (NYSE:HHLA – Get Free Report) and Exact Sciences (NASDAQ:EXAS – Get Free Report) are both financial services companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, risk, dividends, institutional ownership, profitability and analyst recommendations. Institutional and Insider Ownership 39.2% of HH&L […]

Exact Sciences to Present Late-Breaking Data from Pivotal BLUE-C Study on Next-Generation Cologuard at ACG 2023 - Exact Sciences (NASDAQ:EXAS) - Vimarsana News

Exact Sciences to Present Late-Breaking Data from Pivotal BLUE-C Study on Next-Generation Cologuard at ACG 2023 - Exact Sciences (NASDAQ:EXAS)

MADISON, Wis., Oct. 9, 2023 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ:EXAS), a leading provider of cancer screening and diagnostic tests, today announced the company will present late-breaking data on next-generation